|
BE580490A
(fr)
|
1958-07-15 |
1960-01-08 |
Merck & Co Inc |
Compositions et procédés pour abaisser la teneur en cholestérol du sang
|
|
US3383281A
(en)
|
1961-09-22 |
1968-05-14 |
Merck & Co Inc |
Method for binding bile acids in vivo
|
|
US3308020A
(en)
|
1961-09-22 |
1967-03-07 |
Merck & Co Inc |
Compositions and method for binding bile acids in vivo including hypocholesteremics
|
|
US3287370A
(en)
|
1965-06-08 |
1966-11-22 |
Mcneilab Inc |
Tetrahydrobenzothiepins
|
|
US3389144A
(en)
|
1965-06-08 |
1968-06-18 |
Mcneilab Inc |
5-pyridyl-2, 3, 4, 5-tetrahydrobenzothiepin-5-ols
|
|
DE1593760A1
(de)
|
1967-02-01 |
1972-06-08 |
Boehringer Sohn Ingelheim |
Verfahren zur Herstellung neuer Benz-epinderivate
|
|
US3444176A
(en)
|
1967-04-28 |
1969-05-13 |
Mcneilab Inc |
Certain 4-diloweralkylamino-lower alkyl - 5 - pyridyl (or phenyl)-2,3-dihydro - 1 - benzothiepins and derivatives thereof
|
|
GB1269551A
(en)
|
1969-03-27 |
1972-04-06 |
Science Union & Cie |
New tricyclic derivatives and process for their manufacture
|
|
NL7017227A
(OSRAM)
|
1969-12-27 |
1971-06-29 |
|
|
|
US3694446A
(en)
|
1970-02-24 |
1972-09-26 |
William J Houlihan |
5-(substituted-benzyl)-benzocycloheptenes and-1-benzthiepines
|
|
CH531000A
(de)
|
1970-03-11 |
1972-11-30 |
Sandoz Ag |
Verfahren zur Herstellung neuer Benzocycloheptathiophene
|
|
CH537404A
(de)
|
1970-09-24 |
1973-05-31 |
Sandoz Ag |
Verfahren zur Herstellung neuer Thiophenderivate
|
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
|
US3821249A
(en)
|
1970-03-13 |
1974-06-28 |
En Nom Collectif Science Union |
Dibenzothiazefin derivatives
|
|
GB1348642A
(en)
|
1970-10-15 |
1974-03-20 |
Howard A N |
Hypocholesterolaemic compositions
|
|
US3769399A
(en)
|
1971-03-05 |
1973-10-30 |
L Hagerman |
Intestinal bile acid binding process and compositions
|
|
JPS4711953U
(OSRAM)
|
1971-03-08 |
1972-10-12 |
|
|
|
GB1428110A
(en)
|
1972-05-30 |
1976-03-17 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical antihypertensive and vasodilator compositions
|
|
US3974272A
(en)
|
1972-09-01 |
1976-08-10 |
Merck & Co., Inc. |
Palatable cholestyramine coacervate compositions
|
|
CH582699A5
(OSRAM)
|
1973-03-26 |
1976-12-15 |
Sandoz Ag |
|
|
CH593970A5
(en)
|
1973-03-30 |
1977-12-30 |
Hoffmann La Roche |
10-(4-Substd. piperazino) dibenzo (b,f) thiepins - CNS depressants without cataleptic side-effects
|
|
US4044010A
(en)
|
1973-03-30 |
1977-08-23 |
Hoffmann-La Roche Inc. |
Dibenzo[b,f] thiepins bearing piperazinyl substitution
|
|
US3954764A
(en)
|
1973-03-30 |
1976-05-04 |
Hoffmann-La Roche Inc. |
Dibenzo [b,f]thiepins bearing piperazinyl substitution
|
|
US3928383A
(en)
|
1973-06-08 |
1975-12-23 |
Hoffmann La Roche |
Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins
|
|
DK169075A
(da)
|
1974-05-10 |
1975-11-11 |
Ciba Geigy |
Fremgangsmade til fremstilling af heterocycliske s-imino-s-oxider syreadditionssalte deraf samt anvendelse deraf
|
|
SE420725B
(sv)
|
1974-09-26 |
1981-10-26 |
Ciba Geigy Ag |
Sett att framstella 2,3-dihydro-1-benstiepin-4-karboxylsyraamider
|
|
US4252790A
(en)
|
1974-10-23 |
1981-02-24 |
Interx Research Corporation |
Method for treating gastric ulcer-prone patients
|
|
GB1566609A
(en)
|
1977-03-10 |
1980-05-08 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions containing cholestyramine and alginic acid
|
|
US4153612A
(en)
|
1977-10-31 |
1979-05-08 |
The Upjohn Company |
2-Benzoxepins
|
|
US4207239A
(en)
|
1977-10-31 |
1980-06-10 |
The Upjohn Company |
Benzothiepins
|
|
US4251526A
(en)
|
1977-10-31 |
1981-02-17 |
Mccall John M |
2-Benzothiepins and compositions and methods of use therefore
|
|
US4247533A
(en)
|
1978-05-01 |
1981-01-27 |
The Rockefeller University |
Hemoglobin A1c radioimmunoassay
|
|
IT1106718B
(it)
|
1978-12-21 |
1985-11-18 |
Alfa Farmaceutici Spa |
Composizioni a base di resine anioniche salificate farmacologicamente attive
|
|
US5169857A
(en)
|
1988-01-20 |
1992-12-08 |
Bayer Aktiengesellschaft |
7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
|
|
AU548253B2
(en)
|
1981-05-11 |
1985-12-05 |
Pierre Fabre S.A. |
Benzoxepine derivatives and sulphur and nitrogen analogues thereof
|
|
US4647459A
(en)
|
1983-07-20 |
1987-03-03 |
Warner-Lambert Company |
Confectionery compositions containing magnesium trisilicate adsorbates
|
|
US4771072A
(en)
|
1985-01-10 |
1988-09-13 |
Tanabe Seiyaku Co., Ltd. |
Alkoxynaphthalene derivatives
|
|
AU597671B2
(en)
|
1986-06-20 |
1990-06-07 |
Suntory Limited |
2-Phenylbenzoxepin derivative
|
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
|
US4895723A
(en)
|
1986-09-08 |
1990-01-23 |
Amer And Company |
Cholestyramine compositions and method for preparation thereof
|
|
US4814354A
(en)
|
1986-09-26 |
1989-03-21 |
Warner-Lambert Company |
Lipid regulating agents
|
|
ZA876930B
(en)
|
1986-10-07 |
1988-05-25 |
Hoffmann La Roche |
Pharmaceutical compositions
|
|
US5164387A
(en)
|
1988-07-14 |
1992-11-17 |
Hoffmann-Laroche Inc. |
Condensed heterocyclic compounds
|
|
AU626881B2
(en)
|
1988-07-14 |
1992-08-13 |
F. Hoffmann-La Roche Ag |
Benzofused heterocyclics used as pharmaceuticals
|
|
US5158943A
(en)
|
1988-11-21 |
1992-10-27 |
Takeda Chemical Industries, Ltd. |
Sulfur-containing heterocyclic compounds
|
|
US4874744A
(en)
|
1989-03-13 |
1989-10-17 |
University Of Cincinnati |
Method of using melanocyte stimulating hormone as dermatis treatment
|
|
US5275823A
(en)
|
1989-04-27 |
1994-01-04 |
Smith Kline & French Laboratories Ltd. |
Pharmaceutical compositions
|
|
DE3930696A1
(de)
|
1989-09-14 |
1991-03-28 |
Hoechst Ag |
Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
|
|
US4997665A
(en)
|
1989-10-05 |
1991-03-05 |
Michigan Biotechnology Institute |
Dietary fibers and a process for their production
|
|
FR2661676A1
(fr)
|
1990-05-02 |
1991-11-08 |
Lipha |
Derives d'amino benzocycloalcanes, procedes de preparation et medicaments les contenant.
|
|
NZ240846A
(en)
|
1990-12-06 |
1994-04-27 |
Hoechst Ag |
Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
|
|
IT1245890B
(it)
|
1991-04-12 |
1994-10-25 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
|
|
AU1886892A
(en)
|
1991-04-12 |
1992-11-17 |
Schering Corporation |
Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
|
|
ATE175954T1
(de)
|
1991-10-17 |
1999-02-15 |
Shionogi & Co |
Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür
|
|
NZ245503A
(en)
|
1991-12-20 |
1995-11-27 |
Hoechst Ag |
Polymers containing bile acids; pharmaceuticals and preparatory methods
|
|
GB9203347D0
(en)
|
1992-02-17 |
1992-04-01 |
Wellcome Found |
Hypolipidaemic compounds
|
|
DK0573848T3
(da)
|
1992-06-12 |
1998-08-10 |
Hoechst Ag |
Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
|
|
US5415872A
(en)
|
1992-06-22 |
1995-05-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing salts of bile acids
|
|
FR2698873B1
(fr)
|
1992-12-07 |
1995-02-24 |
Lipha |
Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
|
|
IL108634A0
(en)
|
1993-02-15 |
1994-05-30 |
Wellcome Found |
Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
|
|
ZA941003B
(en)
|
1993-02-15 |
1995-08-14 |
Wellcome Found |
Hypolipidaemic compounds
|
|
US5594001A
(en)
|
1993-04-08 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
|
|
US5488134A
(en)
|
1993-04-16 |
1996-01-30 |
Shionogi & Co., Ltd. |
Preparation of compounds of lignan series
|
|
DE4314583A1
(de)
|
1993-04-29 |
1994-11-03 |
Astra Chem Gmbh |
Colestyramin enthaltende Zusammensetzung und Verfahren zu deren Herstellung
|
|
EP0624593A3
(de)
|
1993-05-08 |
1995-06-07 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
|
|
TW289020B
(OSRAM)
|
1993-05-08 |
1996-10-21 |
Hoechst Sktiengesellschaft |
|
|
TW289021B
(OSRAM)
|
1993-05-08 |
1996-10-21 |
Hoechst Ag |
|
|
US5607669A
(en)
|
1994-06-10 |
1997-03-04 |
Geltex Pharmaceuticals, Inc. |
Amine polymer sequestrant and method of cholesterol depletion
|
|
EP0640344B1
(de)
|
1993-08-30 |
1998-10-07 |
Medichemie Ag |
Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform
|
|
US5589358A
(en)
|
1993-12-29 |
1996-12-31 |
Univ Wake Forest |
Ileal bile acid transporter compositions and methods
|
|
US5491152A
(en)
|
1994-03-23 |
1996-02-13 |
The Du Pont Merck Pharmaceutical Company |
Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
|
|
TW474813B
(en)
|
1994-06-10 |
2002-02-01 |
Geltex Pharma Inc |
Alkylated composition for removing bile salts from a patient
|
|
KR970005178Y1
(ko)
|
1994-07-06 |
1997-05-24 |
김상수 |
개량형 노통연관 보일러
|
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
EP0781278B1
(en)
|
1994-09-13 |
2001-03-14 |
Monsanto Company |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US5994391A
(en)
|
1994-09-13 |
1999-11-30 |
G.D. Searle And Company |
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6107494A
(en)
|
1994-09-13 |
2000-08-22 |
G.D. Searle And Company |
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US5547975A
(en)
|
1994-09-20 |
1996-08-20 |
Talley; John J. |
Benzopyranopyrazolyl derivatives for the treatment of inflammation
|
|
US6034118A
(en)
|
1994-11-04 |
2000-03-07 |
Gilead Sciences, Inc. |
Thiepane compounds
|
|
GB9423172D0
(en)
|
1994-11-17 |
1995-01-04 |
Wellcom Foundation The Limited |
Hypolipidemic benzothiazepines
|
|
US6083977A
(en)
|
1994-12-30 |
2000-07-04 |
Ligand Pharmaceuticals Incorporated |
Trienoic retinoid compounds and methods
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
TWI238064B
(en)
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
US5886016A
(en)
|
1995-09-15 |
1999-03-23 |
G.D. Searle & Co. |
Benzopyranopyrazolyl derivatives for the treatment of inflammation
|
|
AU720853B2
(en)
|
1995-11-02 |
2000-06-15 |
Warner-Lambert Company |
Method and pharmaceutical composition for regulating lipid concentration
|
|
DE69733132D1
(de)
|
1996-01-16 |
2005-06-02 |
Ronald J Sokol |
Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
|
|
GB9601697D0
(en)
|
1996-01-27 |
1996-03-27 |
Pfizer Ltd |
Therapeutic agents
|
|
EP0888333B1
(en)
|
1996-03-11 |
2005-08-31 |
G.D. Searle LLC |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
JP2002508652A
(ja)
|
1996-08-23 |
2002-03-19 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
新規なヒト増殖因子
|
|
JPH1072371A
(ja)
|
1996-08-28 |
1998-03-17 |
Sankyo Co Ltd |
回腸型胆汁酸トランスポーター阻害剤
|
|
US6251852B1
(en)
|
1996-09-18 |
2001-06-26 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
|
GB9704208D0
(en)
|
1997-02-28 |
1997-04-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP2002500628A
(ja)
|
1997-03-11 |
2002-01-08 |
ジー．ディー．サール アンド カンパニー |
回腸胆汁酸輸送阻害ベンゾチエピンおよびＨＭＧ Ｃｏ−Ａレダクターゼ阻害剤を用いた併用療法
|
|
PT864582E
(pt)
|
1997-03-14 |
2003-10-31 |
Aventis Pharma Gmbh |
1,4-benzotiazepina-1,1-dioxidos hipolipidemicos
|
|
PT869121E
(pt)
|
1997-04-04 |
2004-10-29 |
Aventis Pharma Gmbh |
Derivados de propanolamina hipolipidemicos
|
|
DE19845402B4
(de)
|
1998-10-02 |
2005-04-07 |
Aventis Pharma Deutschland Gmbh |
Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
IT1292092B1
(it)
|
1997-06-05 |
1999-01-25 |
Geange Ltd |
Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
|
|
WO1998056757A1
(fr)
|
1997-06-11 |
1998-12-17 |
Sankyo Company, Limited |
Derives de benzylamine
|
|
GB9714274D0
(en)
|
1997-07-08 |
1997-09-10 |
Zeneca Ltd |
Pharmaceutical composition
|
|
US6180660B1
(en)
|
1997-08-26 |
2001-01-30 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
US6066336A
(en)
|
1997-09-29 |
2000-05-23 |
Bristol-Myers Squibb Company |
Cholesterol-lowering tablets
|
|
US5900233A
(en)
|
1997-10-16 |
1999-05-04 |
Day; Charles E. |
Epichlorohydrin and 1-(3-aminopropyl) imidazole copolymer and its use in treating irritable bowel syndrome
|
|
US6245797B1
(en)
|
1997-10-22 |
2001-06-12 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
|
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
|
DE19755480A1
(de)
|
1997-12-13 |
1999-06-24 |
Gruenenthal Gmbh |
Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen
|
|
ES2195428T3
(es)
|
1997-12-19 |
2003-12-01 |
Searle & Co |
Metodo para preparar oxidos de tetrahidrobenzotiepina enriquecidos enantiometricamente.
|
|
GB9800428D0
(en)
|
1998-01-10 |
1998-03-04 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6803357B1
(en)
|
1998-02-02 |
2004-10-12 |
New England Medical Center Hospitals, Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
DE19825804C2
(de)
|
1998-06-10 |
2000-08-24 |
Aventis Pharma Gmbh |
1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
JP2000026300A
(ja)
|
1998-07-02 |
2000-01-25 |
Pola Chem Ind Inc |
血管内皮細胞保護医薬組成物
|
|
EP1103552A4
(en)
|
1998-08-07 |
2003-01-15 |
Takeda Chemical Industries Ltd |
BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
|
|
AU5301599A
(en)
|
1998-08-20 |
2000-03-14 |
Takeda Chemical Industries Ltd. |
Quaternary ammonium salts and their use
|
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
|
DE19845403B4
(de)
|
1998-10-02 |
2005-02-10 |
Aventis Pharma Deutschland Gmbh |
Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE19845406C2
(de)
|
1998-10-02 |
2001-10-18 |
Aventis Pharma Gmbh |
Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
AU1684400A
(en)
|
1998-12-11 |
2000-07-03 |
Sankyo Company Limited |
Substituted benzylamines
|
|
WO2000037455A1
(en)
|
1998-12-21 |
2000-06-29 |
Takeda Chemical Industries, Ltd. |
Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5
|
|
PT1140188E
(pt)
*
|
1998-12-23 |
2003-10-31 |
Searle Llc |
Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares.
|
|
DE69911058T2
(de)
|
1998-12-23 |
2004-06-03 |
G.D. Searle Llc, Chicago |
Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen
|
|
HK1045114A1
(zh)
|
1998-12-23 |
2002-11-15 |
G‧D‧瑟尔有限公司 |
适用於心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合
|
|
BR9916484A
(pt)
*
|
1998-12-23 |
2002-01-22 |
Searle Llc |
Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares
|
|
AU3694600A
(en)
|
1999-02-12 |
2000-08-29 |
G.D. Searle Llc |
Novel 1,2-benzothiazepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
SE9901387D0
(sv)
*
|
1999-04-19 |
1999-04-19 |
Astra Ab |
New pharmaceutical foromaulations
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
CZ290178B6
(cs)
|
1999-07-22 |
2002-06-12 |
Sankyo Company Limited |
Deriváty cyklobutenu
|
|
AU7703400A
(en)
|
1999-09-14 |
2001-04-17 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
AU1302301A
(en)
|
1999-11-08 |
2001-06-06 |
Sankyo Company Limited |
Nitrogenous heterocycle derivatives
|
|
WO2001052823A2
(en)
*
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
|
ES2487897T3
(es)
|
2000-01-21 |
2014-08-25 |
Novartis Ag |
Combinaciones que consisten de inhibidores de la dipeptidilpeptidasa-IV y agentes antidiabéticos
|
|
SE0000772D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2001240115A1
(en)
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
|
WO2001068096A2
(en)
|
2000-03-10 |
2001-09-20 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
|
CA2401290A1
(en)
|
2000-04-12 |
2001-10-18 |
Takeda Chemical Industries, Ltd. |
Novel g protein-coupled receptor protein and dna thereof
|
|
US20020183307A1
(en)
|
2000-07-26 |
2002-12-05 |
Tremont Samuel J. |
Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
|
|
RU2241462C2
(ru)
|
2000-07-28 |
2004-12-10 |
Ф. Хоффманн-Ля Рош Аг |
Новая фармацевтическая композиция
|
|
SE0003766D0
(sv)
|
2000-10-18 |
2000-10-18 |
Astrazeneca Ab |
Novel formulation
|
|
ATE466939T1
(de)
|
2000-11-17 |
2010-05-15 |
Banyu Pharma Co Ltd |
Verfahren zur suche nach komponenten, in dem das guanosintriphosphat- (gtp-) bindungsprotein gekoppeltes rezeptorprotein bg37 verwendet wird
|
|
ES2277890T3
(es)
|
2000-12-21 |
2007-08-01 |
Sanofi-Aventis Deutschland Gmbh |
Nuevas difenilazetidinonas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para el tratamiento de trastornos del metabolismo de lipidos.
|
|
EG26979A
(en)
|
2000-12-21 |
2015-03-01 |
Astrazeneca Ab |
Chemical compounds
|
|
CZ20032039A3
(cs)
|
2001-01-26 |
2004-01-14 |
Schering Corporation |
Farmaceutický prostředek
|
|
AU2002306868A1
(en)
|
2001-03-28 |
2002-10-15 |
Pharmacia Corporation |
Therapeutic combinations for cardiovascular and inflammatory indications
|
|
UA76475C2
(en)
|
2001-07-19 |
2006-08-15 |
Pharmacia Corp |
Combination of eplerenon and hmg co-a reductase inhibitor and its use for treatment and/or prophylaxis of pathologic condition in cardiovascular system
|
|
HUP0401318A3
(en)
|
2001-08-22 |
2008-03-28 |
Sanofi Aventis Deutschland |
Combined preparations containing 2,3,4,5-tetrahydro-benzo[b]thiepine-1,1-dioxide derivatives and other active substances, and the use thereof
|
|
GB0121337D0
(en)
|
2001-09-04 |
2001-10-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121621D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121622D0
(en)
*
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2003022286A1
(en)
|
2001-09-08 |
2003-03-20 |
Astrazeneca Ab |
Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
|
|
US7227019B2
(en)
|
2001-09-13 |
2007-06-05 |
Bristol-Myers Squibb Company |
Process for the preparation of rebeccamycin and analogs thereof
|
|
DE60216300T2
(de)
|
2001-09-21 |
2007-06-28 |
Schering Corp. |
Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
|
|
CA2776522C
(en)
|
2001-10-01 |
2015-02-17 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Development of a preventive vaccine for filovirus infection in primates
|
|
CA2464685A1
(en)
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
|
AU2003207431A1
(en)
|
2002-01-17 |
2003-09-02 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
US20040014806A1
(en)
|
2002-03-08 |
2004-01-22 |
Pharmacia Corporation |
Methods and compositions for lowering levels of blood lipids
|
|
GB0209467D0
(en)
|
2002-04-25 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
US6987121B2
(en)
*
|
2002-04-25 |
2006-01-17 |
Smithkline Beecham Corporation |
Compositions and methods for hepatoprotection and treatment of cholestasis
|
|
JP2005531570A
(ja)
|
2002-05-23 |
2005-10-20 |
ユーエムディー， インコーポレイテッド |
貫粘膜薬物送達及び凍結保護のための組成物及び方法
|
|
GB0213669D0
(en)
|
2002-06-14 |
2002-07-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0216321D0
(en)
|
2002-07-13 |
2002-08-21 |
Astrazeneca Ab |
Therapeutic treatment
|
|
CN100494185C
(zh)
|
2002-08-28 |
2009-06-03 |
旭化成制药株式会社 |
新型季铵化合物
|
|
US7312208B2
(en)
|
2002-08-28 |
2007-12-25 |
Asahi Kasei Pharma Corporation |
Quaternary ammonium compounds
|
|
AU2003291719A1
(en)
|
2002-11-06 |
2004-06-03 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
US20040122033A1
(en)
|
2002-12-10 |
2004-06-24 |
Nargund Ravi P. |
Combination therapy for the treatment of obesity
|
|
FR2848452B1
(fr)
|
2002-12-12 |
2007-04-06 |
Aventis Pharma Sa |
Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
|
|
US20040138145A1
(en)
|
2002-12-12 |
2004-07-15 |
Aventis Pharma S.A. |
Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease
|
|
US20040147774A1
(en)
|
2002-12-20 |
2004-07-29 |
Aventis Pharma S.A. |
Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid
|
|
US20050031651A1
(en)
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
GB0304194D0
(en)
|
2003-02-25 |
2003-03-26 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2517573C
(en)
|
2003-03-07 |
2011-12-06 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
CN1756756A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
GB0307918D0
(en)
|
2003-04-05 |
2003-05-14 |
Astrazeneca Ab |
Therapeutic use
|
|
JP2005044778A
(ja)
|
2003-07-19 |
2005-02-17 |
Samsung Sdi Co Ltd |
電界発光素子
|
|
JP2005097216A
(ja)
|
2003-09-26 |
2005-04-14 |
Kaneka Corp |
ＰＰＡＲγリガンド剤
|
|
EP1680189A2
(en)
|
2003-11-05 |
2006-07-19 |
Schering Corporation |
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
|
|
EP1564554A1
(en)
|
2004-02-12 |
2005-08-17 |
Pepscan Systems B.V. |
Method for the detection of early B cell populations in vaccine development
|
|
ATE555101T1
(de)
*
|
2004-02-27 |
2012-05-15 |
Asahi Kasei Pharma Corp |
Neue benzothiazepin- und benzothiepinverbindungen
|
|
DE102004016845A1
(de)
|
2004-04-07 |
2005-10-27 |
Bayer Healthcare Ag |
Phenylthioessigsäure-Derivate und ihre Verwendung
|
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
|
EP1799263A4
(en)
|
2004-09-15 |
2009-07-29 |
Harvard College |
REDUCTION OF ER-STRESS IN THE TREATMENT OF ADIPOSITAS AND DIABETES
|
|
DE102004046623A1
(de)
|
2004-09-25 |
2006-03-30 |
Bayer Healthcare Ag |
Neue Pyrimidin-Derivate und ihre Verwendung
|
|
WO2006039334A1
(en)
|
2004-09-29 |
2006-04-13 |
Schering Corporation |
Combinations of substituted azetidonones and cb1 antagonists
|
|
WO2006041150A1
(ja)
|
2004-10-15 |
2006-04-20 |
Mitsubishi Pharma Corporation |
糖尿病の予防および／または治療薬
|
|
KR20070068407A
(ko)
|
2004-10-25 |
2007-06-29 |
노파르티스 아게 |
Ｄｐｐ―ｉｖ 억제제, ｐｐａｒ 항당뇨병제 및메트포르민의 조합물
|
|
CN101065110A
(zh)
|
2004-11-24 |
2007-10-31 |
柳署弘 |
水溶胆汁酸制剂的干燥形式：制备及其用途
|
|
DE102004058062A1
(de)
|
2004-12-02 |
2006-06-08 |
Bayer Healthcare Ag |
Cyclische Iminocarbamate und ihre Verwendung
|
|
WO2006060461A1
(en)
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
|
WO2006086727A2
(en)
|
2005-02-09 |
2006-08-17 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
US20060193895A1
(en)
|
2005-02-25 |
2006-08-31 |
Use-Techno Corporation |
Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4
|
|
DE102005027150A1
(de)
|
2005-03-12 |
2006-09-28 |
Bayer Healthcare Ag |
Pyrimidincarbonsäure-Derivate und ihre Verwendung
|
|
FR2883284A1
(fr)
|
2005-03-15 |
2006-09-22 |
Commissariat Energie Atomique |
Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
|
|
UY29445A1
(es)
|
2005-03-30 |
2006-10-02 |
Generex Pharm Inc |
Composiciones para la transmisión transmucosa oral de la metformina
|
|
US20080031968A1
(en)
|
2005-04-01 |
2008-02-07 |
The Brigham And Women's Hospital, Inc. |
Methods for increasing cellular energy expenditure
|
|
WO2006105912A2
(en)
|
2005-04-04 |
2006-10-12 |
Julius-Maximilians-Universität Würzburg |
Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
|
|
US9155778B2
(en)
|
2005-04-04 |
2015-10-13 |
Julius-Maxmillians-Universitat Wurzburg |
Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1
|
|
JP2008539255A
(ja)
|
2005-04-26 |
2008-11-13 |
マイクロビア インコーポレーテッド |
高コレステロール血症のための４−ビアリーリル−１−フェニルアゼチジン−２−オングルクロニド誘導体
|
|
DE102005020229A1
(de)
|
2005-04-30 |
2006-11-09 |
Bayer Healthcare Ag |
Verwendung von Indolin-Phenylsulfonamid-Derivaten
|
|
WO2006116814A1
(en)
|
2005-05-02 |
2006-11-09 |
Vanadis Bioscience Ltd |
Composition and uses thereof
|
|
WO2006121861A2
(en)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
|
TW200740752A
(en)
|
2005-05-13 |
2007-11-01 |
Microbia Inc |
4-Biarylyl-1-phenylazetidin-2-ones
|
|
CA2608709A1
(en)
*
|
2005-05-31 |
2006-12-07 |
Novartis Ag |
Treatment of liver diseases in which iron plays a role in pathogenesis
|
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
|
US20070025953A1
(en)
|
2005-07-27 |
2007-02-01 |
Jones Michael R |
Co-therapy for diabetic conditions
|
|
WO2007035703A1
(en)
|
2005-09-20 |
2007-03-29 |
Schering Corporation |
1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
|
|
EP1940388A2
(en)
|
2005-09-30 |
2008-07-09 |
Novartis AG |
Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection
|
|
US8366650B2
(en)
|
2005-10-24 |
2013-02-05 |
Satiogen Pharmaceuticals, Inc. |
Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases
|
|
US7705028B2
(en)
|
2005-12-19 |
2010-04-27 |
Glaxosmithkline Llc |
Farnesoid X receptor agonists
|
|
WO2007075702A2
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
|
|
CA2637057A1
(en)
|
2006-01-13 |
2007-07-26 |
Schering Corporation |
Diaryl piperidines as cb1 modulators
|
|
AR059021A1
(es)
|
2006-01-18 |
2008-03-05 |
Schering Corp |
Moduladores de receptores cannabinoides
|
|
CN101404987A
(zh)
|
2006-01-20 |
2009-04-08 |
史密丝克莱恩比彻姆公司 |
磺酰胺衍生物在治疗代射和神经系统疾病中的用途
|
|
CN101395170A
(zh)
|
2006-02-14 |
2009-03-25 |
英特塞普特药品公司 |
用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
|
|
DE102006009813A1
(de)
|
2006-03-01 |
2007-09-06 |
Bayer Healthcare Ag |
Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel
|
|
WO2007123949A2
(en)
|
2006-04-21 |
2007-11-01 |
Schering Corporation |
Cannabinoid receptor modulators
|
|
DE102006024024A1
(de)
|
2006-05-23 |
2007-11-29 |
Bayer Healthcare Aktiengesellschaft |
Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung
|
|
DE102006026583A1
(de)
|
2006-06-07 |
2007-12-13 |
Bayer Healthcare Aktiengesellschaft |
Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
|
|
DE102006026585A1
(de)
|
2006-06-07 |
2007-12-13 |
Bayer Healthcare Aktiengesellschaft |
Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
|
|
WO2008002573A2
(en)
|
2006-06-27 |
2008-01-03 |
Intercept Pharmaceuticals, Inc. |
Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
|
|
US20080065136A1
(en)
|
2006-08-30 |
2008-03-13 |
Andrew Young |
Distender device and method for treatment of obesity and metabolic and other diseases
|
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
|
DE102006043520A1
(de)
|
2006-09-12 |
2008-03-27 |
Bayer Healthcare Ag |
2-Phenoxynikotinsäure-Derivate und ihre Verwendung
|
|
DE102006043519A1
(de)
|
2006-09-12 |
2008-03-27 |
Bayer Healthcare Ag |
4-Phenoxynikotinsäure-Derivate und ihre Verwendung
|
|
US20080070984A1
(en)
|
2006-09-15 |
2008-03-20 |
Tran Pierre V |
Compositions and Methods of Treating Schizophrenia
|
|
JP2010503677A
(ja)
|
2006-09-15 |
2010-02-04 |
シェーリング コーポレイション |
脂質代謝の障害を治療するためのアゼチジノン誘導体
|
|
WO2008033460A2
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Treating pain, diabetes, and lipid metabolism disorders
|
|
EP2061796A2
(en)
|
2006-09-15 |
2009-05-27 |
Schering Corporation |
Azetidine and azetidinone derivatives useful in treating pain and disorders of lipid metabolism
|
|
AR062789A1
(es)
|
2006-09-15 |
2008-12-03 |
Schering Corp |
Derivados de azetidina y azetidona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del dolor y de trastornos del metabolismo de los lipidos.
|
|
WO2008033465A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Azetidinone derivatives and methods of use thereof
|
|
CN101541795A
(zh)
|
2006-09-15 |
2009-09-23 |
先灵公司 |
用于治疗疼痛、糖尿病和脂类代谢紊乱的螺-稠合氮杂环丁烷衍生物
|
|
US20080070890A1
(en)
|
2006-09-15 |
2008-03-20 |
Burnett Duane A |
Spirocyclic Azetidinone Compounds and Methods of Use Thereof
|
|
DE102006044696A1
(de)
|
2006-09-22 |
2008-03-27 |
Bayer Healthcare Ag |
3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung
|
|
WO2008039829A2
(en)
|
2006-09-26 |
2008-04-03 |
Ironwood Pharmaceuticals, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
|
CL2007003035A1
(es)
|
2006-10-24 |
2008-05-16 |
Smithkline Beechman Corp |
Compuestos derivados de isoxazol sustituidos, agonistas de receptores farnesoid x; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso del compuesto en el tratamiento de la obesidad, diabetes mellitus, fibrosis en organos,
|
|
WO2008052044A2
(en)
|
2006-10-26 |
2008-05-02 |
Xenoport, Inc. |
Use of derivatives of propofol for treating diseases associated with oxidative stress
|
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE102006053637B4
(de)
*
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
JP2010509252A
(ja)
|
2006-11-14 |
2010-03-25 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
改善された特性を有する新規な１，４−ベンゾチエピン−１，１−ジオキシド誘導体、それらの製造方法、上記化合物を含有する薬物、及びそれらの使用
|
|
US20090035306A1
(en)
|
2006-11-29 |
2009-02-05 |
Kalypsys, Inc. |
Quinazolinone modulators of tgr5
|
|
DE102006056740A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102006056739A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
|
|
JP2010517941A
(ja)
|
2007-01-16 |
2010-05-27 |
ザ バーナム インスティテュート フォー メディカル リサーチ |
結腸直腸癌の治療のための組成物および方法
|
|
CA2928178C
(en)
|
2007-01-19 |
2019-09-10 |
Intercept Pharmaceuticals, Inc. |
Tgr5 modulators and methods of use thereof
|
|
WO2008097976A1
(en)
|
2007-02-09 |
2008-08-14 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
DE102007009494A1
(de)
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
|
WO2008124505A2
(en)
|
2007-04-05 |
2008-10-16 |
Ironwood Pharmaceuticals,Inc. |
Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
|
|
US20100197564A1
(en)
|
2007-04-19 |
2010-08-05 |
Schering Corporation |
Diaryl morpholines as cb1 modulators
|
|
NZ583369A
(en)
|
2007-08-23 |
2011-08-26 |
Theracos Inc |
Benzylbenzene derivatives and methods of use
|
|
WO2009115398A1
(en)
*
|
2008-03-18 |
2009-09-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Vitamin d compounds for the treatment of biliary diseases
|
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
|
EA020310B1
(ru)
|
2008-07-30 |
2014-10-30 |
Интерсепт Фармасьютикалз, Инк. |
Модуляторы рецептора tgr5 и их применение
|
|
AU2009316566B9
(en)
|
2008-11-19 |
2014-05-15 |
Intercept Pharmaceuticals, Inc. |
TGR5 modulators and method of use thereof
|
|
EP2364161B1
(en)
|
2008-11-26 |
2020-03-11 |
Satiogen Pharmaceuticals, Inc. |
Compositions containing satiogens and methods of use
|
|
CN102316872B
(zh)
|
2008-11-26 |
2016-12-21 |
萨蒂奥根制药公司 |
治疗肥胖症和糖尿病的胆汁酸再循环抑制剂
|
|
US20110065676A1
(en)
|
2009-06-24 |
2011-03-17 |
Schering Corporation |
Combination therapies comprising par1 antagonists with nar agonists
|
|
JP5909774B2
(ja)
|
2009-08-25 |
2016-04-27 |
クィン ビル セラピューティクス インコーポレイテッド |
胆道疾患を治療するためのポリヒドロキシル化胆汁酸
|
|
US20110152204A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Satiogen Pharmaceuticals, Inc. |
Treatment of Obesity or Diabetes with Bile Acid Sequestrants
|
|
EP3593802A3
(en)
|
2010-05-26 |
2020-03-25 |
Satiogen Pharmaceuticals, Inc. |
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
|
|
KR101890959B1
(ko)
*
|
2010-11-04 |
2018-08-22 |
알비레오 에이비 |
간질환 치료를 위한 ｉｂａｔ 억제제
|
|
US20120114588A1
(en)
|
2010-11-08 |
2012-05-10 |
Albireo Ab |
Ibat inhibitors for treatment of metabolic disorders and related conditions
|
|
CN103228270B
(zh)
|
2010-11-08 |
2016-02-10 |
阿尔比里奥公司 |
含ibat抑制剂和胆汁酸结合剂的药物组合
|
|
MY176863A
(en)
|
2010-11-08 |
2020-08-24 |
Albireo Ab |
Ibat inhibitors for treatment of metabolic disorders and related conditions
|
|
WO2013063526A1
(en)
|
2011-10-28 |
2013-05-02 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
|
|
EA030839B1
(ru)
|
2011-10-28 |
2018-10-31 |
ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи |
Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
|
|
US9007272B2
(en)
|
2012-07-19 |
2015-04-14 |
Tensorcom, Inc. |
Method and apparatus for the alignment of a 60 GHz endfire antenna
|
|
JP2016514684A
(ja)
|
2013-03-15 |
2016-05-23 |
ルメナ ファーマシューティカルズ エルエルシー |
原発性硬化性胆管炎および炎症性腸疾患の処置のための胆汁酸再循環阻害剤
|
|
HUE071511T2
(hu)
|
2016-03-31 |
2025-09-28 |
Genfit |
Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra
|
|
MX2019012535A
(es)
|
2017-04-18 |
2020-08-17 |
Genfit |
Combinacion que comprende un agonista de ppar tal como elafibranor y un inhibidor de la acetil-coa carboxilasa (acc).
|